Dilated Cardiomyopathy Type 1G — A Silent Threat Uncovered
Note: Real cases, names and ages have been changed for privacy.
The Family
Elena and Chris had a family history of heart disease but no known diagnoses. Their pediatrician recommended Fore Genomics screening for their son, Henry.
The Genetic Finding
Henry’s test showed a mutation in the TTN gene, linked to Dilated Cardiomyopathy Type 1G (DCM1G). This condition causes the heart to enlarge and weaken over time, often without symptoms until a dangerous heart event occurs.
The Impact
- Henry underwent baseline cardiac imaging at age 1, which was normal.
- He now has annual heart checks.
- The same mutation was later found in Chris (his father), who had never been tested.
Chris was stunned to learn he carried the same condition and grateful his son’s test may have saved them both.
Today, both father and son are under monitoring, with lifestyle changes and medical oversight reducing their risk of heart failure.
Why It Matters
Without this insight, Henry’s first sign of illness could have come far too late. Now, his family has time and options.
Final Takeaway
Genetic screening is not about fear — it’s about preparation. These case studies show how insights from DNA can:
- Prevent emergencies
- Enable early treatment
- Guide lifelong health decisions
Knowing early meant they could take action – not just for Henry but for the whole family.
FAQs
What is Dilated Cardiomyopathy Type 1G?
It’s an inherited heart condition that causes the heart to enlarge and weaken over time, often silently, until a serious heart event occurs.
Why does an early genetic finding matter for heart conditions?
It allows baseline imaging and ongoing monitoring before symptoms appear, and it can reveal the same risk in other family members — as it did for Henry’s father.